Literature DB >> 22721420

Multiple indicators model of long-term mortality in traumatic brain injury.

Primoz Gradisek1, Josko Osredkar, Marjan Korsic, Boriana Kremzar.   

Abstract

OBJECTIVE: To examine the prognostic ability of protein S100B, neuron-specific enolase (NSE) and glial fibrillary acid protein (GFAP) for prediction of 1-year mortality in patients with traumatic brain injury (TBI) in relation to clinical and radiological characteristics of TBI.
METHODS: Brain injury was quantified in 84 patients (Glasgow Coma Scale [GCS] ≤ 12) using clinical (GCS, pupils), radiological (computed tomography [CT] classification and individual CT characteristics) and biochemical (S100B, NSE and GFAP) data at admission and in the acute post-injury period.
RESULTS: Initial and peak S100B, NSE and GFAP concentrations were higher in non-survivors (n = 26) than in survivors (p-value range: <0.001-0.018). Cox regression showed that GFAP and S100B concentration and the temporal profile of S100B were more powerful independent predictors of mortality than baseline clinical and radiological characteristics or clinical and radiological indicators of neurological deterioration. The prognostic models containing admission variables and those available during the subsequent clinical course showed the same discrimination ability (area under receiver characteristic curve 0.92), but the model based on variables available in the acute post-injury period calibrated better (p = 0.428).
CONCLUSION: Mortality at 1-year post-TBI is accurately predicted by the combination of GFAP and S100B concentration and clinical and radiological characteristics at admission or in the acute post-injury period.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721420     DOI: 10.3109/02699052.2012.694567

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  20 in total

1.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

2.  Role of comprehensive nursing care in improving the prognosis and mood of patients with secondary cerebral infarction after craniocerebral injury.

Authors:  Deyan Cao; Nina Chu; Hongyan Yu; Meihua Sun
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury.

Authors:  Eric P Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

4.  Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.

Authors:  Alex P Di Battista; John E Buonora; Shawn G Rhind; Michael G Hutchison; Andrew J Baker; Sandro B Rizoli; Ramon Diaz-Arrastia; Gregory P Mueller
Journal:  Front Neurol       Date:  2015-05-26       Impact factor: 4.003

Review 5.  The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis.

Authors:  Feng Cheng; Qiang Yuan; Jian Yang; Wenming Wang; Hua Liu
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

6.  Tissue damage markers after a spinal manipulation in healthy subjects: a preliminary report of a randomized controlled trial.

Authors:  A Achalandabaso; G Plaza-Manzano; R Lomas-Vega; A Martínez-Amat; M V Camacho; M Gassó; F Hita-Contreras; F Molina
Journal:  Dis Markers       Date:  2014-12-25       Impact factor: 3.434

7.  Plasma levels of S100B in preeclampsia and association with possible central nervous system effects.

Authors:  Lina Bergman; Tansim Akhter; Anna-Karin Wikström; Johan Wikström; Tord Naessen; Helena Åkerud
Journal:  Am J Hypertens       Date:  2014-03-07       Impact factor: 2.689

8.  The utility of biomarkers in traumatic brain injury clinical management.

Authors:  Ana Rodríguez-Rodríguez; Juan José Egea-Guerrero
Journal:  Crit Care       Date:  2016-11-18       Impact factor: 9.097

9.  Higher mortality rates among the elderly with mild traumatic brain injury: a nationwide cohort study.

Authors:  Po-Liang Cheng; Hsin-Yi Lin; Yi-Kung Lee; Chen-Yang Hsu; Ching-Chih Lee; Yung-Cheng Su
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-01-28       Impact factor: 2.953

Review 10.  Blood Biomarkers for Evaluation of Perinatal Encephalopathy.

Authors:  Ernest M Graham; Irina Burd; Allen D Everett; Frances J Northington
Journal:  Front Pharmacol       Date:  2016-07-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.